First Spark Ventures is a venture capital firm focused on deep tech, investing in scientists globally. Based in Menlo Park, California, it backs early-stage startups through pre-seed, seed, and Series A rounds, with a focus on biotechnology, digital biology, advanced computing, cyber-physical systems, and advanced materials. The organization aims to enable scientific founders to translate discovery into practical applications by partnering with teams that combine rigorous science with scalable technology, providing capital, mentorship, and ecosystem access to accelerate commercialization and impact.
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.
Vitara Biomedical
Series B in 2022
Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.